Company intelligence / Profile preview

Hoofprint Biome

Raleigh, North Carolina, United Stateshoofprintbiome.com ↗

Ownership: Private
Employees: ~15
Development stage: Other

Overview

Hoofprint Biome has developed a proprietary platform that uses AI to discover natural enzymes capable of reshaping the rumen microbiome. Their lead product is a yeast-based probiotic delivering these enzymes to cattle, aiming to reduce methane emissions while improving animal health and productivity. The company has demonstrated rapid progress with promising pre-clinical results and is moving toward on-farm trials

Therapeutic areas: Metabolic DisordersOther
Modalities: ProbioticEnzyme-based therapyMicrobial therapyYeast-based delivery system (Saccharomyces boulardii)
Industry: Non-Drug Biotech

Partnerships

AgriZeroNZ investment partnershiplicensing patents from North Carolina State Universitysupported by Breakthrough Energy Ventures and other climate/agtech investors

Beyond the preview

Go deeper on Hoofprint Biome.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hoofprint Biome.

Explore the full profile